Division of Clinical Genetics
671 – 680 of 1343
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
CYTOGENETIC AND MOLECULAR GENETIC CHARACTERIZATION OF LIPOMAS
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
(
- Contribution to journal › Article
-
Mark
Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage-Activating Agents
2011) Annual Meeting on the United States and Canadian-Academy-of-Pathology, 2011 In Laboratory Investigation 91(Feb 26 - Mar 4, 2011). p.10-10(
- Contribution to journal › Published meeting abstract
-
Mark
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study
(
- Contribution to journal › Article
-
Mark
Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
(
- Contribution to journal › Article
-
Mark
Chromosome banding analysis of cells from fine-needle aspiration biopsy samples from soft tissue and bone tumors: is it clinically meaningful?
(
- Contribution to journal › Article
-
Mark
MUC4 Is a Highly Sensitive and Specific Marker for Low-Grade Fibromyxoid Sarcoma
2011) Annual Meeting on the United States and Canadian-Academy-of-Pathology, 2011 In Laboratory Investigation 91. p.12-12(
- Contribution to journal › Published meeting abstract